Diabetes Atherosclerosis Intervention Study (DAIS): Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) |
Rim Halaby (talk | contribs) |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
The Diabetes Atherosclerosis Intervention Study (DAIS) is a double- | The Diabetes Atherosclerosis Intervention Study (DAIS) is a double-blinded placebo-controlled study that assessed the rate of [[cardiovascular disease]] following the administration of 200 mg fenofibrate in non-insulin-dependent diabetes subjects.<ref name="pmid9081851">{{cite journal| author=Steiner G| title=The Diabetes Atherosclerosis Intervention Study (DAIS): a study conducted in cooperation with the World Health Organization. The DAIS Project Group. | journal=Diabetologia | year= 1996 | volume= 39 | issue= 12 | pages= 1655-61 | pmid=9081851 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9081851 }} </ref> | ||
==References== | ==References== | ||
Latest revision as of 03:05, 19 August 2014
|
High Density Lipoprotein Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Clinical Trials |
|
Case Studies |
|
Diabetes Atherosclerosis Intervention Study (DAIS) On the Web |
|
American Roentgen Ray Society Images of Diabetes Atherosclerosis Intervention Study (DAIS) |
|
Diabetes Atherosclerosis Intervention Study (DAIS) in the news |
|
Risk calculators and risk factors for Diabetes Atherosclerosis Intervention Study (DAIS) |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]
Overview
The Diabetes Atherosclerosis Intervention Study (DAIS) is a double-blinded placebo-controlled study that assessed the rate of cardiovascular disease following the administration of 200 mg fenofibrate in non-insulin-dependent diabetes subjects.[1]
References
- ↑ Steiner G (1996). "The Diabetes Atherosclerosis Intervention Study (DAIS): a study conducted in cooperation with the World Health Organization. The DAIS Project Group". Diabetologia. 39 (12): 1655–61. PMID 9081851.